CD19-positive antibody-secreting cells provide immune memory Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Key Points CD19+ and negative ASCs share a development path and are both capable of providing long-lasting immune memory. Most ASCs are targets of early chimeric antigen receptor–T-cell therapy; knowing this may help to improve current cancer treatments.

authors

  • Groves, CJ
  • Carrell, J
  • Grady, R
  • Rajan, B
  • Morehouse, CA
  • Halpin, R
  • Wang, J
  • Wu, J
  • Shrestha, Y
  • Rayanki, R
  • Kolbeck, Roland
  • Wang, Y
  • Herbst, R

publication date

  • November 27, 2018